pharmaceutical investing Sage Announces Pivotal Phase 3 Trial Status for SAGE-217 in Major Depressive Disorder and Postpartum Depression based on FDA Breakthrough Therapy Meetin
LaFleur Minerals Commences Diamond Drilling at the Swanson Gold Deposit and Completes Independent Valuation of the Beacon Gold Mill
